vs

Side-by-side financial comparison of TANDEM DIABETES CARE INC (TNDM) and WESBANCO INC (WSBC). Click either name above to swap in a different company.

WESBANCO INC is the larger business by last-quarter revenue ($257.2M vs $247.2M, roughly 1.0× TANDEM DIABETES CARE INC). WESBANCO INC runs the higher net margin — 34.5% vs -8.2%, a 42.7% gap on every dollar of revenue. Over the past eight quarters, WESBANCO INC's revenue compounded faster (31.9% CAGR vs 5.5%).

Tandem Diabetes Care, Inc. is an American medical device manufacturer based in San Diego, California. The company develops medical technologies for the treatment of diabetes and specifically insulin infusion therapy.

WesBanco, Inc., is a bank holding company headquartered in Wheeling, West Virginia, United States. It has over 200 branches in West Virginia, Ohio, Western Pennsylvania, Kentucky, Maryland, and Southern Indiana.

TNDM vs WSBC — Head-to-Head

Bigger by revenue
WSBC
WSBC
1.0× larger
WSBC
$257.2M
$247.2M
TNDM
Higher net margin
WSBC
WSBC
42.7% more per $
WSBC
34.5%
-8.2%
TNDM
Faster 2-yr revenue CAGR
WSBC
WSBC
Annualised
WSBC
31.9%
5.5%
TNDM

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
TNDM
TNDM
WSBC
WSBC
Revenue
$247.2M
$257.2M
Net Profit
$-20.4M
$88.6M
Gross Margin
55.3%
Operating Margin
37.6%
Net Margin
-8.2%
34.5%
Revenue YoY
5.5%
Net Profit YoY
54.4%
EPS (diluted)
$-0.30
$0.88

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
TNDM
TNDM
WSBC
WSBC
Q1 26
$247.2M
$257.2M
Q4 25
$290.4M
$265.6M
Q3 25
$249.3M
$261.6M
Q2 25
$240.7M
$260.7M
Q1 25
$234.4M
$193.2M
Q4 24
$282.6M
$162.9M
Q3 24
$244.0M
$150.8M
Q2 24
$221.9M
$147.9M
Net Profit
TNDM
TNDM
WSBC
WSBC
Q1 26
$-20.4M
$88.6M
Q4 25
$-589.0K
$91.1M
Q3 25
$-21.2M
$83.6M
Q2 25
$-52.4M
$57.4M
Q1 25
$-130.6M
$-9.0M
Q4 24
$755.0K
$49.6M
Q3 24
$-23.3M
$37.3M
Q2 24
$-30.8M
$28.9M
Gross Margin
TNDM
TNDM
WSBC
WSBC
Q1 26
55.3%
Q4 25
57.7%
Q3 25
53.9%
Q2 25
52.3%
Q1 25
50.5%
Q4 24
55.7%
Q3 24
51.1%
Q2 24
50.8%
Operating Margin
TNDM
TNDM
WSBC
WSBC
Q1 26
37.6%
Q4 25
2.9%
43.2%
Q3 25
-9.2%
39.5%
Q2 25
-21.5%
27.2%
Q1 25
-51.6%
-5.0%
Q4 24
-0.2%
38.0%
Q3 24
-10.7%
29.7%
Q2 24
-13.9%
23.7%
Net Margin
TNDM
TNDM
WSBC
WSBC
Q1 26
-8.2%
34.5%
Q4 25
-0.2%
34.3%
Q3 25
-8.5%
31.9%
Q2 25
-21.8%
22.0%
Q1 25
-55.7%
-4.7%
Q4 24
0.3%
30.5%
Q3 24
-9.5%
24.7%
Q2 24
-13.9%
19.5%
EPS (diluted)
TNDM
TNDM
WSBC
WSBC
Q1 26
$-0.30
$0.88
Q4 25
$0.02
$0.97
Q3 25
$-0.31
$0.84
Q2 25
$-0.78
$0.57
Q1 25
$-1.97
$-0.15
Q4 24
$0.00
$0.72
Q3 24
$-0.35
$0.54
Q2 24
$-0.47
$0.44

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
TNDM
TNDM
WSBC
WSBC
Cash + ST InvestmentsLiquidity on hand
$570.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$132.4M
$4.1B
Total Assets
$1.2B
$27.5B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
TNDM
TNDM
WSBC
WSBC
Q1 26
$570.3M
Q4 25
$292.7M
$956.1M
Q3 25
$319.1M
$1.0B
Q2 25
$315.4M
$1.2B
Q1 25
$368.6M
$1.1B
Q4 24
$438.3M
$568.1M
Q3 24
$473.3M
$620.9M
Q2 24
$452.4M
$486.8M
Stockholders' Equity
TNDM
TNDM
WSBC
WSBC
Q1 26
$132.4M
$4.1B
Q4 25
$155.2M
$4.0B
Q3 25
$133.0M
$4.1B
Q2 25
$133.3M
$3.8B
Q1 25
$155.3M
$3.8B
Q4 24
$263.1M
$2.8B
Q3 24
$237.7M
$2.8B
Q2 24
$233.9M
$2.5B
Total Assets
TNDM
TNDM
WSBC
WSBC
Q1 26
$1.2B
$27.5B
Q4 25
$881.1M
$27.7B
Q3 25
$874.7M
$27.5B
Q2 25
$875.7M
$27.6B
Q1 25
$922.1M
$27.4B
Q4 24
$967.7M
$18.7B
Q3 24
$957.7M
$18.5B
Q2 24
$937.5M
$18.1B

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

TNDM
TNDM

Segment breakdown not available.

WSBC
WSBC

Net Interest Income$215.4M84%
Noninterest Income$41.8M16%

Related Comparisons